NIH-funded research R01 grant

Investigating how exogenous AMH affects ovarian function and fertility

Official title: Evaluation of the effect of exogenous AMH on ovarian function and fertility

Funded at Massachusetts General Hospital · NIH-11141413 · Data updated 2026-11-12

This study is looking at how a hormone called anti-Müllerian hormone (AMH) affects women's ovaries, with the goal of finding out if it can help improve fertility or be used for contraception, which could lead to new treatments for fertility problems and age-related ovarian issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 5, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$724,714
NIH project number1R01HD115719-01A1
Project IDNIH-11141413 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women experiencing fertility issues or those at risk of ovarian aging due to medical treatments.

Less likely to help

Patients who are not seeking to conceive or who have no concerns regarding ovarian function may not benefit from this research.

What this research studies

This research explores the role of anti-Müllerian hormone (AMH) in regulating ovarian function and its potential applications in women's health. By using non-human primates as a model, the study aims to understand how AMH can inhibit follicle activation and growth, and whether higher levels of AMH can safely enhance fertility or provide contraception. The findings could lead to new treatments for conditions related to ovarian aging and fertility issues. The research will involve administering AMH and monitoring its effects on ovarian function over time.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that improve fertility and protect against ovarian aging in women.

How similar studies have gone: While research on AMH has been conducted in animal models, this approach using non-human primates is relatively novel and aims to bridge the gap in understanding its effects in humans.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Pepin, David — Massachusetts General Hospital
  • Study coordinator: Pepin, David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.